Skip to main content

Table 3 Factors associated with ART uptake and VL suppression among HIV-infected patients in care in the ARCs (2011), Belgium

From: Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants

  ART uptake VL suppression
Characteristic On ART OR for no ART uptake (95 % CI) AORa for no ART uptake (95 % CI) AORb for no ART uptake (95 % CI) Undetectable VL OR for detectable VL (95 % CI) AORa for detectable VL (95 % CI)
Sex        
 Male 84.5 % 1 1 1 83.7 % 1 1
 Female 84.9 % 0.97 (0.87–1.09) 1.38 (1.14–1.67) 1.16 (0.85–1.58) 82.9 % 1.06 (0.93–1.19) 0.84 (0.70–1.01)
Age at diagnosis        
  <40 years 84.0 % 1 1 1 82.3 % 1 1
  ≥40 years 85.5 % 0.89 (0.78–1.01) 0.88 (0.76–1.02) 0.74 (0.60–0.91) 85.2 % 0.81 (0.70–0.93) 0.83 (0.71–0.97)
Way of transmission        
 Heterosexual 85.9 % 1 1 1 82.6 % 1 1
 MSM 81.8 % 1.36 (1.19–1.55) 1.54 (1.27–1.88) 0.98 (0.73–1.32) 84.8 % 0.85 (0.74–0.98) 0.88 (0.72–1.07)
 IDU 85.6 % 1.02 (0.66–1.59) 1.01 (0.64–1.60) 0.75 (0.27–2.11) 82.5 % 1.01 (0.65–1.56) 1.04 (0.66–1.65)
Nationality        
 Belgian 83.8 % 1 1 1 85.1 % 1 1
 SSA 86.4 % 0.81 (0.71–0.93) 0.87 (0.73–1.05) 0.89 (0.65–1.21) 81.3 % 1.31 (1.14–1.52) 1.25 (1.04–1.51)
 European 82.5 % 1.10 (0.88–1.37) 1.14 (0.91–1.44) 0.84 (0.61–1.15) 84.2 % 1.07 (0.83–1.38) 1.01 (0.77–1.32)
 Other 81.9 % 1.14 (0.90–1.45) 1.13 (0.89–1.45) 1.17 (0.81–1.67) 81.1 % 1.33 (1.03–1.73) 1.21 (0.92–1.59)
Reason for testing        
 Patient’s request 76.7 % 1 1 1 82.6 % 1 1
 Clinical arguments 86.2 % 0.53 (0.45–0.62) 0.57 (0.48–0.67) 0.77 (0.61–0.97) 82.9 % 0.98 (0.82–1.18) 0.96 (0.79–1.16)
 Preoperative 78.8 % 0.89 (0.62–1.27) 0.95 (0.64–1.40) 1.82 (0.95–3.52) 88.2 % 0.64 (0.38–1.07) 0.65 (0.38–1.11)
 Other 83.5 % 0.65 (0.54–0.78) 0.73 (0.60–0.89) 0.92 (0.68–1.25) 83.7 % 0.93 (0.75–1.15) 0.87 (0.69–1.10)
CD4 at first visit        
 CD4≥350 58.5 % 1 1 / 76.5 % 1 1
 CD4≥200 & <350 88.0 % 0.19 (0.15–0.25) 0.19 (0.14–0.26) / 78.2 % 0.91 (0.70–1.17) 0.83 (0.62–1.10)
 CD4<200 94.0 % 0.09 (0.06–0.13) 0.09 (0.06–0.14) / 74.6 % 1.10 (0.87–1.41) 1.03 (0.78–1.37)
Time since HIV diagnosis       
  <1 year 54.2 % 1 1 1 49.2 % 1 1
 1 – <5 years 78.3 % 0.33 (0.28–0.39) 0.32 (0.27–0.39) 0.26 (0.21–0.33) 81.5 % 0.22 (0.18–0.27) 0.22 (0.17–0.27)
 5 – <10 years 89.3 % 0.14 (0.12–0.17) 0.13 (0.11–0.16) 0.12 (0.07–0.19) 88.4 % 0.13 (0.10–0.16) 0.12 (0.09–0.15)
  ≥10 years 94.5 % 0.07 (0.06–0.08) 0.06 (0.05–0.07) / 85.9 % 0.16 (0.13–0.20) 0.14 (0.11–0.18)
  1. p < 0.05, statistically significant variables presented in boldface
  2. aAdjusted for sex, age at diagnosis, nationality, way of transmission
  3. bAdditional adjustment for CD4 value at first visit (only includes patients diagnosed between 2006 and 2011, n = 2437)